Postoperative Hip Precautions After Total Hip Arthroplasty Via the Posterior Approach: A Prospective Randomized Trial

November 13, 2025 updated by: Omar Behery, Rush University Medical Center

Are Postoperative Hip Precautions Necessary After a Total Hip Arthroplasty Via the Posterior Approach: A Prospective Randomized Trial

The purpose of this study is to determine if hip precautions, which are instructions that limit functional use of a hip replacement after surgery, affect the rate of dislocation in the first six weeks after primary total hip replacement surgery. The impact of hip precautions on a patient's return to activities of daily living and overall patient satisfaction will also be investigated. The overall cost effectiveness of hip precautions will be determined.

Study Overview

Detailed Description

This study examines the necessity of postoperative hip precautions in patients after primary total hip arthroplasty via the posterior approach. Precautions are instructions that limit the functional use of the hip and are given for the first six weeks after surgery, with the goal of preventing an instability event resulting in dislocation. The hip precautions that will be investigated in this study are: no hip flexion past 90º, no crossing the legs, and no twisting at the waist.

Study Type

Interventional

Enrollment (Actual)

1133

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60612
        • Rush University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients undergoing a primary total hip arthroplasty via the posterior approach by participating attending surgeons at this institution
  • Index diagnosis of noninflammatory arthritis
  • Patients must be able to understand and comply with study procedures

Exclusion Criteria:

  • Allergy or intolerance to the study materials
  • History of previous surgeries on the affected joint other than arthroscopy; i.e. revision THA or open surgeries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: No Hip Precautions
Patients will not be prescribed hip precautions in the first 6 weeks after surgery. The hip precautions that will no longer be prescribed are: no hip flexion past 90º, no crossing the legs, and no twisting at the waist.
Patients will not be prescribed hip precautions in the first 6 weeks after surgery. The hip precautions that will no longer be prescribed are: no hip flexion past 90º, no crossing the legs, and no twisting at the waist.
Active Comparator: Hip Precautions
Patients will receive the following hip precautions: no hip flexion past 90º, no crossing the legs, and no twisting at the waist for the first six weeks after surgery.
Hip precautions are functional limitations of the hip replacement prescribed to patients for the first six weeks after surgery and are no hip flexion past 90º, no crossing the legs, and no twisting at the waist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dislocation
Time Frame: 6 weeks after surgery
Incidence of dislocation of the total hip arthroplasty will be recorded for both treatment groups.
6 weeks after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Activities of Daily Living
Time Frame: 1 year after surgery
The time from surgery to return to activities of daily living will be measured for both treatment groups. This includes return to activities of bathing, return to work, and return to driving.
1 year after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Use of Assistive Devices After Surgery
Time Frame: 6 months after surgery
Patients will be surveyed in clinic after surgery about their use of assistive devices including seat extenders, extra pillows between the legs, and walkers. The use of these devices between groups will be compared and the cost per patient in each group for use of these devices will be determined, allowing for analysis of potential cost savings for patients not prescribed hip precautions.
6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Omar Behery, MD, Orthopedics Surgeon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

July 21, 2025

Study Completion (Actual)

November 1, 2025

Study Registration Dates

First Submitted

January 11, 2016

First Submitted That Met QC Criteria

February 15, 2016

First Posted (Estimated)

February 19, 2016

Study Record Updates

Last Update Posted (Estimated)

November 14, 2025

Last Update Submitted That Met QC Criteria

November 13, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Clinical Trials on No Hip Precautions

Subscribe